Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
3(38%)

Phase Distribution

Ph phase_3
2
25%
Ph not_applicable
2
25%
Ph phase_1
3
38%
Ph phase_2
1
13%

Phase Distribution

3

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(3)
Terminated(4)
Other(1)

Detailed Status

Completed3
Terminated3
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (37.5%)
Phase 21 (12.5%)
Phase 32 (25.0%)
N/A2 (25.0%)

Trials by Status

unknown113%
completed338%
withdrawn113%
terminated338%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL

NCT01228331
completedphase_3

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery

NCT01372774
withdrawnnot_applicable

Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery

NCT02277561
completednot_applicable

Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34

NCT01176487
terminatedphase_1

Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

NCT01018836
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01228331Phase 2

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL

Completed
NCT01372774Phase 3

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery

Completed
NCT02277561Not Applicable

Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery

Withdrawn
NCT01176487Not Applicable

Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34

Completed
NCT01018836Phase 1

Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Terminated
NCT00955695Phase 3

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Unknown
NCT00937482Phase 1

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Terminated
NCT00892801Phase 1

Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

Terminated

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8